Article Details

Fate Therapeutics (NASDAQ:FATE) Receives New Coverage from Analysts at Citigroup

Retrieved on: 2018-08-26 14:01:58

Tags for this article:

Click the tags to see associated articles and topics

Fate Therapeutics (NASDAQ:FATE) Receives New Coverage from Analysts at Citigroup. View article details on hiswai:

Excerpt

<div>Finally, <b>Two Sigma Investments</b> LP acquired a new position in shares of Fate Therapeutics during the 4th quarter worth approximately $1,043,000.</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo